Investigational Drug Details
| Drug ID: | D405 |
| Drug Name: | Evoglitin |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | 1222102-29-5 |
| Repositioning for NAFLD: | No |
| SMILES: | O=C1NCCN(C(=O)CC(N)CC2=CC(F)=C(F)C=C2F)C1COC(C)(C)C |
| Structure: |
|
| InChiKey: | LCDDAGSJHKEABN-MLGOLLRUSA-N |
| Molecular Weight: | 401.42 |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | DPP-4 inhibitor |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 4 completed (NCT03910361) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0054 | NCT03910361 | Phase 4 | Completed | No Results Available | April 12, 2019 | April 29, 2021 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|